Advancing first-of-its kind biomarker driven therapy in ovarian cancer.
About Zentalis
Improving Patient lives
We are a clinical-stage biopharmaceutical company focused on developing differentiated small molecule therapeutics targeting fundamental biologic pathways of cancers.
